Mitochondrial dysfunction activates MHC class I adaptive immune responses in lung aging

T. Meul (Munich, Germany), X. Wang (Munich, Germany), I. Angelidis (Munich, Germany), K. Berschneider (Munich, Germany), S. Schmitt (Munich, Germany), H. Zischka (Munich, Germany), C. Toerne (Munich, Germany), S. Hauck (Munich, Germany), H. Schiller (Munich, Germany), S. Meiners (Munich, Germany)

Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology
Session: Cellular metabolism and immune senescence in lung pathology
Session type: Oral Presentation
Number: 3589
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Abstract

Aging is strongly associated with pulmonary disorders. Mitochondrial dysfunction is a hallmark of aging and a driving pathomechanism of age-related lung diseases. Mitochondrial stress and released mtDNA has been shown to activate innate immune responses via DNA sensing. However, whether mitochondrial stress also regulates adaptive immune responses such as MHC I antigen presentation has not been investigated so far. We here investigated regulation of MHC I antigen presentation by mitochondrial stress using proteomic analysis of aged mouse lungs and an in vitro model of chronic mitochondrial dysfunction.

Proteomic analysis of young versus aged mouse lungs revealed an age-related signature of mitochondrial dysfunction with reduced expression of proteins involved in oxidative phosphorylation but prominent induction of the MHC I antigen presentation pathway. In cells derived from the mutator mouse model, which represents a system of premature aging, disturbed mitochondrial function resulted in a concerted upregulation of the MHC I antigen presentation pathway as demonstrated by proteomic and FACS analysis. Importantly, expression and activity of the immunoproteasome (IP), a specialized type of proteasome involved in the generation of antigenic MHC I peptides was strongly upregulated compared to controls. Induction was driven by activation of STAT1 via cGAS/STING DNA sensors as shown by silencing experiments.

In conclusion, our findings show that dysfunctional mitochondria induce stress signaling to activate IP function and MHC I antigen presentation. In the aging lung defective mitochondrial function might thereby contribute to autoimmunity via altered MHC class I antigen presentation. 



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Meul (Munich, Germany), X. Wang (Munich, Germany), I. Angelidis (Munich, Germany), K. Berschneider (Munich, Germany), S. Schmitt (Munich, Germany), H. Zischka (Munich, Germany), C. Toerne (Munich, Germany), S. Hauck (Munich, Germany), H. Schiller (Munich, Germany), S. Meiners (Munich, Germany). Mitochondrial dysfunction activates MHC class I adaptive immune responses in lung aging. 3589

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC - 2020 - Mitochondrial dysfunction induce immunoproteasome and MHC class I responses in lung aging
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020


Mitochondrial DNA stress activates MHC class I antigen presentation and CD8+ T-cell immunity: implications for pulmonary fibrosis
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021

PP209 – Mitochondrial DNA stress activates MHC class I antigen presentation and CD8+ Tcell immunity: implications for pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

LSC - 2021 - Mitochondrial DNA stress activates MHC class I antigen presentation and CD8+ T-cell immunity: implications for pulmonary fibrosis
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021

Linking proteostasis to immune activation in the ageing lung
Source: ERS Lung Science Conference 2020
Year: 2020

Adaptive immune responses and protein homeostasis in COPD: the immunoproteasome
Source: Eur Respir J, 59 (3) 2102557; 10.1183/13993003.02557-2021
Year: 2022



Detection of thoracotomy-induced alterations in cell- and humoral mediated immune response
Source: Eur Respir J 2003; 22: Suppl. 45, 368s
Year: 2003

Immunology and defence mechanism of the developing lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60
Year: 2006

miRNAs and the regulation of the lung innate immune response
Source: Annual Congress 2009 - miRNAs in inflammation and disease
Year: 2009


Role of mitochondria in the activation of immune cells in the lung
Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Year: 2018


Innate and adaptive immune response in lung diseases
Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Year: 2019


Overview of innate and adaptive immune responses in the airways
Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
Year: 2021


Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005

Polymorphisms of innate immune response genes and severe systemic inflammatory response syndromes
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010


The role of innate immune cells in inflammation
Source: International Congress 2015 – Resolving inflammation
Year: 2015



Graphene may modulate the immune activation and survival of monocytes representative of the innate immunity
Source: Annual Congress 2012 - Indoor and outdoor air pollution
Year: 2012

RCT Abstract - Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021